Studies relating vitamin C deficiency to rheumatic fever and rheumatoid arthritis; experimental, clinical and general considerations II. Rheumatoid (atrophic) arthritis

被引：26

|

作者：

Rinehart, JF

机构：

来源：

ANNALS OF INTERNAL MEDICINE | 1935年 / 9卷 / 06期

关键词：

D O I：

10.7326/0003-4819-9-6-671

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：671 / 689

页数：19

相关论文

共 26 条

[21] Studies of hemolytic streptococcal antibodies in control groups, rheumatic fever, and rheumatoid arthritis I. The incidence of antistreptolysin "O", antifibrinolysin, and hemolytic streptococcal precipitating antibodies in the sera of urban control groups
Mote, JR
Jones, TD
JOURNAL OF IMMUNOLOGY, 1941, 41 (01): : 35 - 60
[22] The clinical utility of measuring C-terminal telopeptides of type II collagen (CTX-II) in patients with Rheumatoid and Psoriatic Arthritis following anti-TNF-α therapy
Morrin, M.
FitzGerald, O.
McKenna, M. J.
Brady, J. J.
Murray, B. F.
IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S559 - S560
[23] RADIOGRAPHIC ASSESSMENT OF DISEASE PROGRESSION IN RHEUMATOID-ARTHRITIS PATIENTS ENROLLED IN THE COOPERATIVE SYSTEMATIC STUDIES OF THE RHEUMATIC DISEASES PROGRAM RANDOMIZED CLINICAL-TRIAL OF METHOTREXATE, AURANOFIN, OR A COMBINATION OF THE 2
LOPEZMENDEZ, A
DANIEL, WW
READING, JC
WARD, JR
ALARCON, GS
ARTHRITIS AND RHEUMATISM, 1993, 36 (10): : 1364 - 1369
[24] Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review
Pincus, T
Ferraccioli, G
Sokka, T
Larsen, A
Rau, R
Kushner, I
Wolfe, F
RHEUMATOLOGY, 2002, 41 (12) : 1346 - 1356
[25] The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CrX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy
Morrin, M. A.
Fitzgerald, O.
McKenna, M. J.
Brady, J. J.
Murray, B. F.
BONE, 2009, 44 (02) : S273 - S274
[26] Safety and clinical activity of ocrelizumab (a humanized antibody targeting C D20+B cells) in combination with methotrexate (M T X) in moderate-severe rheumatoid arthritis (R A) patients (pts) (Ph I/II A C T IONstudy).
Genovese, M. C.
Kaine, J. L.
Kohen, M. D.
Lowenstein, M. B.
Del Giudice, J.
Baldassare, A. R.
Schechtman, J.
Gujrathi, S.
Trapp, R. G.
Sweiss, N. J.
Spaniolo, D. G.
Dummer, W.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S66 - S67